Ilyang opens biggest vaccine plant

Published: 2011-04-13 06:56:00

Updated: 2011-04-13 06:56:00

Ilyang Pharmaceutical Co. said it has completed its vaccine plant with an annual egg-based production capacity of 60 million doses of influenza vaccine in Jecheon, North Chungcheong Province.

A completion ceremony was held Monday, 12 months after the ground was broken last May.

Llyang devel...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK